Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-001302

Chief Executive Officer bought 3,000 shares at an average $2.09 ($6,280)

From the SEC's structured data for this filing

Trades in this filing

Nijhawan Pardeep · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Purchase : show line 1 in the form +2,000 $2.00 $4,000 627,813 D
2026-03-02 Purchase : show line 2 in the form +1,000 $2.28 $2,280 372,702 I
Open-market purchases · 3,000 sh · avg $2.09 · $6,280
Loading xslF345X05/ownership.xml…